Genmab — Juni 2020

[Solsen]

Det er hurtigt !

[E_L]

@Solsen it was written exactly like that in the press release " For the discovery research partnership, Genmab will conduct Phase 1 studies for these programs. AbbVie retains the right to opt-in to program development."

[GeorgeBest]

@kkjoel 11:42 Ikke nogen opdatering på Bloomberg kursmål det senste år, kan ikke gå længere tilbage

[E_L]

Bryan Garnier höjer riktkursen för Genmab till 2 000 danska kronor (1 950), upprepar neutral - BN (Finwire)

[Sukkeralf]

E L - and there is a opt in payment thats not included in the 2 billion milestones

[E_L]

are
you sure it is not included?

[Solsen]

Yes but the question yesterday was - is
these programs in clinical developement alredy. NO

[Sukkeralf]

E L - pretty sure Jan said that. But it could be a small amount

[E_L]

ok

[E_L]

Genmab/Citi: Abbvie-aftale er bedre end ventet https://npinvestor.dk/nyheder/genmabciti-abbvie-aftale-er-bedre-end-ventet

[E_L]

H.C. Wainwright analyst Raghuram Selvaraju raised the firm's price target on Genmab to $40 from $34 and keeps a Buy rating on the shares. The analyst views AbbVie as a "solid partner" for Genmab alongside Janssen

The Fly | LANDINGPAGENEWS.PHP

Real-time market news, financial data, stock research, and portfolio tools from The Fly.

(thefly.com)

[GeorgeBest]

GENMAB A/S GMAB.O: SUNTRUST ROBINSON RAISES TARGET PRICE TO $39 FROM $36 - Reuters News

[bikube]

MedWatch påstår, at Guggenheims nye kursmål på 2350 er det hidtil højeste. Har vi ikke set mål på 2500?

[GeorgeBest]

Jo UBS og Citi har 2500

[kkjoel]

Og nu osse H.C. Wainright ($40 ~ 2620 (kurs 6,55)) samt Suntrust Robinson ($39 ~ 2555).

[kkjoel]

Jeg har noteret 30 finanshusmål med snit på 1931.

[E_L]

Abbvie at GS conference from minute 29 https://kvgo.com/GSHC/AbbVie-june-2020

[GeorgeBest]

thanks E L

[E_L]

and Seattle Genetics from minute 13:50 for TV
https://kvgo.com/GSHC/seattle-genetics-june-2020

[GeorgeBest]

Its a full time job for you to keep up updated E L